KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
Kristin Meliambro(Icahn School of Medicine at Mount Sinai), Kirk N. Campbell(University of Pennsylvania), Evren U. Azeloglu(Icahn School of Medicine at Mount Sinai), John Cijiang He(James J. Peters VA Medical Center), Yanfeng Yang(First Affiliated Hospital of Zhengzhou University), Jonathan C. Haydak(Icahn School of Medicine at Mount Sinai), Estefania Rodriguez Ballestas(Icahn School of Medicine at Mount Sinai), Jia Fu(Harbin Medical University), Caroline Malkin(Icahn School of Medicine at Mount Sinai), Fadi Salem(Icahn School of Medicine at Mount Sinai), John M. Basgen(University of Minnesota), John R. Lee(Cornell University), Laura Mariani(University of Michigan), Ronald E. Gordon(New York University), Huei Hsun Wen(Icahn School of Medicine at Mount Sinai), Jenny Wong(Georgia State University), Marina de Cos(Icahn School of Medicine at Mount Sinai)
Cited by 9
Related Papers
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
|Cell Systems|2017|449
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
|Kidney International|2002|377
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy
|Kidney International|2002|331
Glomerular endothelial cell injury and cross talk in diabetic kidney disease
|American Journal of Physiology-Renal Physiology|2014|274
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
|American Journal of Kidney Diseases|2013|239